A citation-based method for searching scientific literature

Denis O'Mahony, David O'Sullivan, Stephen Byrne, Marie Noelle O'Connor, Cristin Ryan, Paul Gallagher. Age Ageing 2015
Times Cited: 1134







List of co-cited articles
394 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



What is polypharmacy? A systematic review of definitions.
Nashwa Masnoon, Sepehr Shakib, Lisa Kalisch-Ellett, Gillian E Caughey. BMC Geriatr 2017
809
17


Reducing inappropriate polypharmacy: the process of deprescribing.
Ian A Scott, Sarah N Hilmer, Emily Reeve, Kathleen Potter, David Le Couteur, Deborah Rigby, Danijela Gnjidic, Christopher B Del Mar, Elizabeth E Roughead, Amy Page,[...]. JAMA Intern Med 2015
657
16


Interventions to improve the appropriate use of polypharmacy for older people.
Audrey Rankin, Cathal A Cadogan, Susan M Patterson, Ngaire Kerse, Chris R Cardwell, Marie C Bradley, Cristin Ryan, Carmel Hughes. Cochrane Database Syst Rev 2018
169
11

Clinical consequences of polypharmacy in elderly.
Robert L Maher, Joseph Hanlon, Emily R Hajjar. Expert Opin Drug Saf 2014
788
9

Appropriate prescribing in elderly people: how well can it be measured and optimised?
Anne Spinewine, Kenneth E Schmader, Nick Barber, Carmel Hughes, Kate L Lapane, Christian Swine, Joseph T Hanlon. Lancet 2007
641
8

Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria.
Fabiane Raquel Motter, Janaína Soder Fritzen, Sarah Nicole Hilmer, Érika Vieira Paniz, Vera Maria Vieira Paniz. Eur J Clin Pharmacol 2018
90
8

Potentially inappropriate medications in the elderly: the PRISCUS list.
Stefanie Holt, Sven Schmiedl, Petra A Thürmann. Dtsch Arztebl Int 2010
470
7



A method for assessing drug therapy appropriateness.
J T Hanlon, K E Schmader, G P Samsa, M Weinberger, K M Uttech, I K Lewis, H J Cohen, J R Feussner. J Clin Epidemiol 1992
572
7

Interventions to optimise prescribing for older people in care homes.
David P Alldred, Mary-Claire Kennedy, Carmel Hughes, Timothy F Chen, Paul Miller. Cochrane Database Syst Rev 2016
131
6


The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'.
Julian Lindsay, Michael Dooley, Jennifer Martin, Michael Fay, Alison Kearney, Mohsina Khatun, Michael Barras. Support Care Cancer 2015
65
9

Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.
Donna M Fick, James W Cooper, William E Wade, Jennifer L Waller, J Ross Maclean, Mark H Beers. Arch Intern Med 2003
6

Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review.
Janine A Cooper, Cathal A Cadogan, Susan M Patterson, Ngaire Kerse, Marie C Bradley, Cristín Ryan, Carmel M Hughes. BMJ Open 2015
173
6

A systematic review and novel classification of listing tools to improve medication in older people.
Farhad Pazan, Jonathan Kather, Martin Wehling. Eur J Clin Pharmacol 2019
25
24

A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.
Andrew M Whitman, Kathlene A DeGregory, Amy L Morris, Erika E Ramsdale. Oncologist 2016
33
15

Association between polypharmacy and death: A systematic review and meta-analysis.
Nattawut Leelakanok, Andrea L Holcombe, Brian C Lund, Xiaomei Gu, Marin L Schweizer. J Am Pharm Assoc (2003) 2017
112
5


Potentially inappropriate medications in the elderly: a French consensus panel list.
Marie-Laure Laroche, Jean-Pierre Charmes, Louis Merle. Eur J Clin Pharmacol 2007
293
5


An update on the clinical consequences of polypharmacy in older adults: a narrative review.
Jonas W Wastesson, Lucas Morin, Edwin C K Tan, Kristina Johnell. Expert Opin Drug Saf 2018
139
5

The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity.
Ryan M Carnahan, Brian C Lund, Paul J Perry, Bruce G Pollock, Kennith R Culp. J Clin Pharmacol 2006
384
5

The anticholinergic risk scale and anticholinergic adverse effects in older persons.
James L Rudolph, Marci J Salow, Michael C Angelini, Regina E McGlinchey. Arch Intern Med 2008
466
5

Inappropriate prescribing: a systematic overview of published assessment tools.
Carole P Kaufmann, Regina Tremp, Kurt E Hersberger, Markus L Lampert. Eur J Clin Pharmacol 2014
131
5

Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial.
Manuel R Blum, Bastiaan T G M Sallevelt, Anne Spinewine, Denis O'Mahony, Elisavet Moutzouri, Martin Feller, Christine Baumgartner, Marie Roumet, Katharina Tabea Jungo, Nathalie Schwab,[...]. BMJ 2021
17
29

Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences.
Denis Curtin, Paul F Gallagher, Denis O'Mahony. Ther Adv Drug Saf 2019
34
14


A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial.
Ulrika Gillespie, Anna Alassaad, Dan Henrohn, Hans Garmo, Margareta Hammarlund-Udenaes, Henrik Toss, Asa Kettis-Lindblad, Håkan Melhus, Claes Mörlin. Arch Intern Med 2009
372
4


The prescribing cascade revisited.
Paula A Rochon, Jerry H Gurwitz. Lancet 2017
81
4

Polypharmacy and potentially inappropriate medication use in geriatric oncology.
Manvi Sharma, Kah Poh Loh, Ginah Nightingale, Supriya G Mohile, Holly M Holmes. J Geriatr Oncol 2016
90
4


PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.
Andrea C Tricco, Erin Lillie, Wasifa Zarin, Kelly K O'Brien, Heather Colquhoun, Danielle Levac, David Moher, Micah D J Peters, Tanya Horsley, Laura Weeks,[...]. Ann Intern Med 2018
4


Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review.
Terri R Fried, John O'Leary, Virginia Towle, Mary K Goldstein, Mark Trentalange, Deanna K Martin. J Am Geriatr Soc 2014
328
4



The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study.
Sture Rognstad, Mette Brekke, Arne Fetveit, Olav Spigset, Torgeir Bruun Wyller, Jørund Straand. Scand J Prim Health Care 2009
159
4

Polypharmacy in elderly patients.
Emily R Hajjar, Angela C Cafiero, Joseph T Hanlon. Am J Geriatr Pharmacother 2007
651
4


Systematic review of anticholinergic risk scales in older adults.
Carlos E Durán, Majda Azermai, Robert H Vander Stichele. Eur J Clin Pharmacol 2013
202
4

The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010.
Bruce Guthrie, Boikanyo Makubate, Virginia Hernandez-Santiago, Tobias Dreischulte. BMC Med 2015
364
4

Systematic review on the use of anticholinergic scales in poly pathological patients.
Angela Maria Villalba-Moreno, Eva Rocío Alfaro-Lara, Maria Concepción Pérez-Guerrero, Maria Dolores Nieto-Martín, Bernardo Santos-Ramos. Arch Gerontol Geriatr 2016
59
6



Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial.
Denis O'Mahony, Adalsteinn Gudmundsson, Roy L Soiza, Mirko Petrovic, Alfonso Jose Cruz-Jentoft, Antonio Cherubini, Richard Fordham, Stephen Byrne, Darren Dahly, Paul Gallagher,[...]. Age Ageing 2020
21
19


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.